BIOGF Biocartis Group NV

USD 0.66 0.00 0
Icon

Biocartis Group NV (BIOGF) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.66

0.00 (0.00)%

USD 0.07B

N/A

N/A

N/A

Icon

BIOGF

Biocartis Group NV (USD)
COMMON STOCK | OTC
USD 0.66
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.07B

N/A

USD 0.66

Biocartis Group NV (BIOGF) Stock Forecast

N/A

Based on the Biocartis Group NV stock forecast from 0 analysts, the average analyst target price for Biocartis Group NV is not available over the next 12 months. Biocartis Group NV’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biocartis Group NV is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Biocartis Group NV’s stock price was USD 0.66. Biocartis Group NV’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Biocartis Group NV
No recent average analyst rating found for Biocartis Group NV

Company Overview Biocartis Group NV

Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time p...Read More

Generaal de Wittelaan 11 B, Mechelen, Belgium, 2800

526

December

USD

USA

Adjusted Closing Price for Biocartis Group NV (BIOGF)

Loading...

Unadjusted Closing Price for Biocartis Group NV (BIOGF)

Loading...

Share Trading Volume for Biocartis Group NV Shares

Loading...

Compare Performance of Biocartis Group NV Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOGF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biocartis Group NV (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LZAGF
Lonza Group Ltd -6.86 (-1.25%) USD42.40B 60.22 29.26

ETFs Containing BIOGF

Symbol Name BIOGF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biocartis Group NV (BIOGF) Stock

Stock Target Advisor's fundamental analysis for Biocartis Group NV's stock is Very Bearish.

Unfortunately we do not have enough data on BIOGF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOGF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIOGF's stock to indicate if its overvalued.

The last closing price of BIOGF's stock was USD 0.66.

The most recent market capitalization for BIOGF is USD 0.07B.

Unfortunately we do not have enough analyst data on BIOGF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biocartis Group NV's stock.

As per our most recent records Biocartis Group NV has 526 Employees.

Biocartis Group NV's registered address is Generaal de Wittelaan 11 B, Mechelen, Belgium, 2800. You can get more information about it from Biocartis Group NV's website at https://www.biocartisgroupnv.be.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...